Obesity speeds up biological aging at the molecular level, but this study finds that a very-low-calorie ketogenic diet (VLCKD ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

Body size and excess weight, conventionally assessed using body mass index (BMI), are well-established risk factors for many types of cancer. However, new research to be presented at this year's ...

Streamlined access to authentic, FDA-approved, rigorously-tested Zepbound comes from Sesame’s direct integration with Gifthealth. Zepbound is the first and only FDA-approved dual glucagon-like peptide ...

Dr. Jen Ashton, who is board-certified in obesity medicine and has a master’s in nutrition, joins TODAY to share insight in eating protein and how it can be different from varying sources.

The licensing pact adds a second so-called "triple agonist" to the Danish drugmaker's portfolio as competition with Lilly and ...

The issuer is solely responsible for the content of this announcement.

Novo Nordisk’s hopes of heralding a new era of obesity treatment with its next-generation CagriSema drug may be in doubt ...

Is immortality achievable? With longevity science booming, you might make it to age 150. We separate the hype from proven ...

The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...